All lobbying filings
GOODRX, INC.
GOODRX, INC. filed a Q4 report for GOODRX, INC. on January 20, 2026.
Lobbying for GOODRX, INC.
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Expenses
$300,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
California
Government bodies contacted
2
Lobbying activity
2
Monitoring federal legislation and outreach to congressional offices.
-Issues regarding prescription drug pricing. -Issues regarding telehealth.